HUDSON, Ohio. - Thursday, March 26th 2015 [ME NewsWire]
(BUSINESS
WIRE)-- Wolters Kluwer, a leading global provider of information for
healthcare professionals and students, announced today that its Clinical
Drug Information unit is strengthening support for customers in the
Asia Pacific region with the release of the new ICD-10-AM v6 – Disease
Mapping™ API. This essential tool will help facilitate the
interoperability required by Australian and other regional customers
employing drug data from the Clinical Drug Information application
Medi-Span®.
ICD-10 is the tenth revision of the International
Statistical Classification of Diseases and Related Health Problems, a
medical classification list of codes that identify various diagnoses,
symptoms, procedures, and other factors involved in reporting and
documenting medical care. The codes, maintained by the World Health
Organization, help create a standard international data vocabulary for
sharing information and communicating diagnoses and other medical
information. ICD-10-AM is the “Australian Modification” code set, which
has been customized and extended to include new codes and conditions
relevant in Australia and the surrounding region.
With the
ICD-10-AM v6 – Disease Mapping API, Medi-Span customers in nations such
as Australia, Singapore and Saudi Arabia will receive the
region-specific data they need to better deliver medication decision
support. This new offering is an application programming interface (API)
that maps Medi-Span proprietary medical condition codes to the
corresponding ICD-10-AM identifiers. This will help improve
interoperability and enhance data-driven clinical screenings, including
for drug-disease contraindications and condition-specific drug dosing.
“Healthcare
professionals in Australia, New Zealand, Singapore, the Middle East and
throughout Asia Pacific need relevant data to power their processes.
They should not be expected to compromise and adapt to codes designed
for the United States, Canada, or Europe,” stated Steven Kerscher, Vice
President & General Manager, Clinical Drug Information, Wolters
Kluwer Health, Clinical Solutions. “The Clinical Drug Information unit
has strong relationships with health systems in the region, and we are
proud to provide the data and data mapping those organizations need to
optimize their clinical systems and deliver the best possible
healthcare.”
About Wolters Kluwer
Wolters Kluwer is a
global leader in professional information services. Professionals in the
areas of legal, business, tax, accounting, finance, audit, risk,
compliance and healthcare rely on Wolters Kluwer’s market leading
information-enabled tools and software solutions to manage their
business efficiently, deliver results to their clients, and succeed in
an ever more dynamic world.
Wolters Kluwer reported 2014 annual
revenues of €3.7 billion. The group serves customers in over 170
countries, and employs over 19,000 people worldwide. The company is
headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer
shares are listed on NYSE Euronext Amsterdam (WKL) and are included in
the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1
American Depositary Receipt program. The ADRs are traded on the
over-the-counter market in the U.S. (WTKWY).
For more information
about our products and organization, visit www.wolterskluwer.com,
follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook,
follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
Contacts
Wolters Kluwer Health | Clinical Solutions
Meagan McCord, 330-650-6506
Manager, Marketing Communications
meagan.mccord@wolterskluwer.com
Permalink: http://me-newswire.net/news/14124/en
No comments:
Post a Comment